The Women’s Health Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing awareness about women’s health issues
The women’s health market is experiencing significant growth due to increasing awareness about women’s health issues. This growth is driven by various factors such as rising healthcare expenditures, advancements in medical technology, and a greater focus on preventive care. There is a growing demand for products and services addressing women’s unique health needs, including reproductive health, maternal health, breast health, menopause management, and sexual health. Additionally, initiatives promoting women’s health education and advocacy have contributed to a greater understanding of gender-specific health concerns and the importance of early detection and treatment. The women’s health market is expected to continue expanding, offering opportunities for innovation and improved healthcare outcomes for women worldwide.
Technological advancements in patient care
Technological advancements are rapidly reshaping the landscape of the women’s health market, ushering in a new era of innovation and improved patient care. From sophisticated diagnostic tools to cutting-edge treatment modalities, these advancements are revolutionizing the way women’s health conditions are diagnosed, managed, and treated. Advanced imaging techniques, such as 3D mammography and MRI, offer greater accuracy in detecting breast cancer at its earliest stages, improving survival rates and reducing the need for invasive procedures. Minimally invasive surgical techniques, including laparoscopy and robotic-assisted surgery, are providing safer and more effective options for addressing gynaecological conditions like endometriosis and fibroids. Moreover, digital health solutions such as mobile apps, wearable devices, and telemedicine platforms are empowering women to take charge of their health by providing convenient access to information, monitoring tools, and virtual consultations with healthcare providers. These technological innovations hold immense promise for enhancing women’s health outcomes, driving market growth, and advancing the overall quality of care in the field of women’s health.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Women’s Health Market evolving?
- What is driving and restraining the Women’s Health Market?
- How will each Women’s Health submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Women’s Health submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Women’s Health Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Women’s Health projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Women’s Health projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Women’s Health Market?
- Where is the Women’s Health Market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Women’s Health Market today, and over the next 10 years:
- Our 351-page report provides 125 tables and 186 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Women’s Health Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Women’s Health prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Application
- Contraceptives
- Postmenopausal osteoporosis
- Hormonal infertility
- Menopause
- Polycystic Ovary Syndrome
- Endometriosis and Uterine Fibroids
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Drugs
- Prolia
- Xgeva
- Mirena
- Nexplanon
- Forteo
- Nuvaring
- Premarin
- Lupron
- Lo Loestrin
- Orilissa/Oriahnn
- Others
By Type
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Women’s Health Market, 2024 to 2034, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
- Abbott
- Bayer AG
- Caldera Medical
- Cardinal Health
- Carestream
- Cooper Surgical Inc.
- L. Hoffman-La Roche Ltd.
- GE Healthcare
- Hologic
- Koninklijke Philips N.V
- MedGyn Products
- Medline Industries, Inc.
- Prestige Consumer Healthcare, Inc.
- Siemens AG
Overall world revenue for Women’s Health Market, 2024 to 2034 in terms of value the market will surpass US$ 61.0 billion in 2034, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Women’s Health Market, 2024 to 2034 report help you?
In summary, our 350+ page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Women’s Health Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 16 key national markets – See forecasts for the Women’s Health Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 14 of the major companies involved in the Women’s Health Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Women’s Health Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Women’s Health Market Report 2024-2034: Forecasts by Application (Contraceptives, Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome (PCOS), Endometriosis and Uterine Fibroids, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Drugs (Xgeva, Prolia, Mirena, Forteo, Premarin, Lupron, Lo Loestrin, Orilissa/Oriahnn), by Generics/Branded (Generics, Branded) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Women’s Health Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Heightened Attention Towards Emerging Economies
3.2.1.2 Escalated Innovation Targeting New Therapeutic Solutions
3.2.1.3 Expanded Investments in Technology to Enhance Patient Satisfaction
3.2.2 Market Restraining Factors
3.2.2.1 Elevated Pricing Poses a Constraint on Market Expansion
3.2.2.2 Increased Collaboration for the Development of Advanced Healthcare Infrastructure
3.2.3 Market Opportunities
3.2.3.1 Expansion of Preventative Care Services Tailored to Women's Unique Health Needs.
3.2.3.2 Improving Digital Health Platforms to Enhance the Access to Healthcare Services for Women, Particularly in Underserved Areas.
3.2.3.3 Technological Advancements in Reproductive Health Services, Including Family Planning, Fertility Management, and Maternal Care
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Women’s Health Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Women’s Health Market Size Estimation and Forecast by Application
4.4 Contraceptives
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Postmenopausal Osteoporosis
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Hormonal Infertility
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Menopause
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Polycystic Ovary Syndrome
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Endometriosis and Uterine Fibroids
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)
5 Women’s Health Market Analysis by Distribution Channel
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Women’s Health Market Size Estimation and Forecast by Distribution Channel
5.4 Hospital Pharmacies
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Retail Pharmacies
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Online Pharmacies
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
6 Women’s Health Market Analysis by Drugs
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Women’s Health Market Size Estimation and Forecast by Drugs
6.4 Xgeva
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Prolia
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Mirena
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Nexplanon
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Forteo
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Nuvaring
6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
6.9.2 Market Share by Region, 2024 & 2034 (%)
6.10 Premarin
6.10.1 Market Size by Region, 2024-2034 (US$ Billion)
6.10.2 Market Share by Region, 2024 & 2034 (%)
6.11 Lupron
6.11.1 Market Size by Region, 2024-2034 (US$ Billion)
6.11.2 Market Share by Region, 2024 & 2034 (%)
6.12 Lo Loestrin
6.12.1 Market Size by Region, 2024-2034 (US$ Billion)
6.12.2 Market Share by Region, 2024 & 2034 (%)
6.13 Orilissa/Oriahnn
6.13.1 Market Size by Region, 2024-2034 (US$ Billion)
6.13.2 Market Share by Region, 2024 & 2034 (%)
6.14 Others
6.14.1 Market Size by Region, 2024-2034 (US$ Billion)
6.14.2 Market Share by Region, 2024 & 2034 (%)
7 Women’s Health Market Analysis by Type
7.1 Key Findings
7.2 Application Segment: Market Attractiveness Index
7.3 Women’s Health Market Size Estimation and Forecast by Type
7.4 Generic
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Branded
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)
8 Women’s Health Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Women’s Health Market Analysis
9.1 Key Findings
9.2 North America Women’s Health Market Attractiveness Index
9.3 North America Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 North America Women’s Health Market Size Estimation and Forecast by Country
9.5 North America Women’s Health Market Size Estimation and Forecast by Application
9.6 North America Women’s Health Market Size Estimation and Forecast by Distribution Channel
9.7 North America Women’s Health Market Size Estimation and Forecast by Drugs
9.8 North America Women’s Health Market Size Estimation and Forecast by Type
9.9 U.S. Women’s Health Market Analysis
9.10 Canada Women’s Health Market Analysis
10 Europe Women’s Health Market Analysis
10.1 Key Findings
10.2 Europe Women’s Health Market Attractiveness Index
10.3 Europe Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Europe Women’s Health Market Size Estimation and Forecast by Country
10.5 Europe Women’s Health Market Size Estimation and Forecast by Application
10.6 Europe Women’s Health Market Size Estimation and Forecast by Distribution Channel
10.7 Europe Women’s Health Market Size Estimation and Forecast by Drugs
10.8 Europe Women’s Health Market Size Estimation and Forecast by Type
10.9 Germany Women’s Health Market Analysis
10.10 France Women’s Health Market Analysis
10.11 UK Women’s Health Market Analysis
10.12 Italy Women’s Health Market Analysis
10.13 Spain Women’s Health Market Analysis
10.14 Russia Women’s Health Market Analysis
10.15 Poland Women’s Health Market Analysis
10.16 Belgium Women’s Health Market Analysis
10.17 Rest of Europe Women’s Health Market Analysis
11 Asia Pacific Women’s Health Market Analysis
11.1 Key Findings
11.2 Asia Pacific Women’s Health Market Attractiveness Index
11.3 Asia Pacific Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Asia Pacific Women’s Health Market Size Estimation and Forecast by Country
11.5 Asia Pacific Women’s Health Market Size Estimation and Forecast by Application
11.6 Asia Pacific Women’s Health Market Size Estimation and Forecast by Distribution Channel
11.7 Asia Pacific Women’s Health Market Size Estimation and Forecast by Drugs
11.8 Asia Pacific Women’s Health Market Size Estimation and Forecast by Type
11.9 Japan Women’s Health Market Analysis
11.10 China Women’s Health Market Analysis
11.11 India Women’s Health Market Analysis
11.12 Australia Women’s Health Market Analysis
11.13 South Korea Women’s Health Market Analysis
11.14 Singapore Women’s Health Market Analysis
11.15 Taiwan Women’s Health Market Analysis
11.16 Rest of Asia Pacific Women’s Health Market Analysis
12 Latin America Women’s Health Market Analysis
12.1 Key Findings
12.2 Latin America Women’s Health Market Attractiveness Index
12.3 Latin America Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Latin America Women’s Health Market Size Estimation and Forecast by Country
12.5 Latin America Women’s Health Market Size Estimation and Forecast by Application
12.6 Latin America Women’s Health Market Size Estimation and Forecast by Distribution Channel
12.7 Latin America Women’s Health Market Size Estimation and Forecast by Drugs
12.8 Latin America Women’s Health Market Size Estimation and Forecast by Type
12.9 Brazil Women’s Health Market Analysis
12.10 Mexico Women’s Health Market Analysis
12.11 Argentina Women’s Health Market Analysis
12.12 Colombia Women’s Health Market Analysis
12.13 Rest of Latin America Women’s Health Market Analysis
13 MEA Women’s Health Market Analysis
13.1 Key Findings
13.2 MEA Women’s Health Market Attractiveness Index
13.3 MEA Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 MEA Women’s Health Market Size Estimation and Forecast by Country
13.5 MEA Women’s Health Market Size Estimation and Forecast by Application
13.6 MEA Women’s Health Market Size Estimation and Forecast by Distribution Channel
13.7 MEA Women’s Health Market Size Estimation and Forecast by Drugs
13.8 MEA Women’s Health Market Size Estimation and Forecast by Type
13.9 GCC Women’s Health Market Analysis
13.10 South Africa Women’s Health Market Analysis
13.11 Rest of MEA Women’s Health Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Summary of all Strategic Outlook
14.3 Abbott Laboratories
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2017-2022
14.3.3.2 R&D, 2017-2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Bayer AG
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2017-2022
14.4.3.2 R&D, 2017-2022
14.4.3.3 Regional Market Shares, 2022
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Caldera Medical Inc.
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Strategic Outlook
14.6 Cardinal Health
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2017-2023
14.6.3.2 Regional Market Shares, 2023
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Carestream Health
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Product Benchmarking
14.7.4 Strategic Outlook
14.8 Cooper Surgical Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2017-2023
14.8.3.2 R&D, 2017-2023
14.8.3.3 Regional Market Shares, 2023
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 L. Hoffman-La Roche Ltd.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2023
14.9.3.2 R&D, 2017-2023
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 General Electric Healthcare
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2017-2022
14.10.3.2 R&D, 2017-2022
14.10.3.3 Regional Market Shares, 2022
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Hologic Inc.
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2017-2023
14.11.3.2 R&D, 2017-2023
14.11.3.3 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 koninklijke philips n.v
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2017-2022
14.12.3.2 R&D, 2017-2022
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 MedGyn Products Inc.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.14 Medline Industries, Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Prestige Consumer Healthcare Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.4 Product Benchmarking
14.16 Siemens AG
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2017-2023
14.16.3.2 R&D, 2017-2023
14.16.3.3 Regional Market Shares, 2023
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
List of Tables
Table 1 Women’s Health Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 7 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 8 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 9 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 15 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Xgeva Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Generic Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Women’s Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 North America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 North America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 North America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 North America Women’s Health Market Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 North America Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 U.S. Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Canada Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 41 Europe Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Europe Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 43 Europe Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Europe Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 Europe Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Germany Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 47 France Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 48 UK Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Italy Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 50 Spain Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Russia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Poland Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Belgium Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Europe Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Asia Pacific Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 57 Asia Pacific Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 58 Asia Pacific Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Asia Pacific Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Japan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 China Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 India Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 63 Australia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 64 South Korea Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 Singapore Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 Taiwan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 Rest of Asia Pacific Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 68 Latin America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Latin America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 70 Latin America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 71 Latin America Women’s Health Market Drugs, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Latin America Women’s Health Market Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 Brazil Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 74 Mexico Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 75 Argentina Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 Colombia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 Rest of Latin America Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 80 MEA Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 81 MEA Women’s Health Market by Drugs, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 82 MEA Women’s Health Market by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 83 GCC Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 84 South Africa Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 85 Rest of MEA Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 86 Strategic Outlook
Table 87 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Abbott Laboratories: Product Benchmarking
Table 89 Abbott Laboratories: Strategic Outlook
Table 90 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Bayer AG: Product Benchmarking
Table 92 Bayer AG: Strategic Outlook
Table 93 Caldera Medical Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Caldera Medical Inc: Product Benchmarking
Table 95 Caldera Medical Inc: Strategic Outlook
Table 96 Cardinal Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Cardinal Health: Product Benchmarking
Table 98 Cardinal Health: Strategic Outlook
Table 99 Carestream health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Carestream Health: Product Benchmarking
Table 101 Carestream Health: Strategic Outlook
Table 102 Cooper Surgical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Cooper Surgical, Inc.: Product Benchmarking
Table 104 Cooper Surgical, Inc.: Strategic Outlook
Table 105 L. Hoffman-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 L. Hoffman-La Roche Ltd.: Product Benchmarking
Table 107 Debiotech SA: Strategic Outlook
Table 108 General Electric Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 General Electric Healthcare: Product Benchmarking
Table 110 General Electric Healthcare: Strategic Outlook
Table 111 Hologic Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Hologic Inc: Product Benchmarking
Table 113 Hologic Inc.: Strategic Outlook
Table 114 koninklijke philips n.v: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Koninklijke Philips N.V: Product Benchmarking
Table 116 Koninklijke Philips N.V: Strategic Outlook
Table 117 MedGyn Products Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 MedGyn Products, Inc.: Product Benchmarking
Table 119 Medline Industries, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Medline Industries Inc: Product Benchmarking
Table 121 Prestige Consumer Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Prestige Consumer Healthcare Inc.: Product Benchmarking
Table 123 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Siemens AG: Product Benchmarking
Table 125 Siemens AG: Strategic Outlook
List of Figures
Figure 1 Women’s Health Market Segmentation
Figure 2 Women’s Health Market by Application: Market Attractiveness Index
Figure 3 Women’s Health Market by Distribution Channel: Market Attractiveness Index
Figure 4 Women’s Health Market by Drugs: Market Attractiveness Index
Figure 5 Women’s Health Market by Type: Market Attractiveness Index
Figure 6 Women’s Health Market Attractiveness Index by Region
Figure 7 Women’s Health Market: Market Dynamics
Figure 8 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 9 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 10 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 11 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 12 Women’s Health Market: Porter’s Five Forces Analysis
Figure 13 Women’s Health Market: PEST Analysis
Figure 14 Women’s Health Market by Application: Market Attractiveness Index
Figure 15 Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 16 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 17 Contraceptives Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Contraceptives Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Postmenopausal Osteoporosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Postmenopausal Osteoporosis Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Hormonal Infertility Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Hormonal Infertility Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Menopause Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Menopause Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Polycystic Ovary Syndrome Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Polycystic Ovary Syndrome Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Endometriosis and Uterine Fibroids Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Endometriosis and Uterine Fibroids Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Women’s Health Market by Distribution Channel: Market Attractiveness Index
Figure 32 Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 33 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 34 Hospital Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Hospital Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Retail Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Retail Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Online Pharmacies Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Online Pharmacies Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Women’s Health Market by Drugs: Market Attractiveness Index
Figure 41 Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 42 Women’s Health Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 43 Xgeva Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Xgeva Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Prolia Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 46 Prolia Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Mirena Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 48 Mirena Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Nexplanon Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 50 Nexplanon Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Forteo Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 52 Forteo Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Nuvaring Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 54 Nuvaring Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Premarin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 56 Premarin Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 Lupron Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 58 Lupron Market Share Forecast by Region, 2024 & 2034 (%)
Figure 59 Lo Loestrin Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 60 Lo Loestrin Market Share Forecast by Region, 2024 & 2034 (%)
Figure 61 Orilissa/Oriahnn Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 62 Orilissa/Oriahnn Market Share Forecast by Region, 2024 & 2034 (%)
Figure 63 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 64 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 65 Women’s Health Market by Type: Market Attractiveness Index
Figure 66 Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 67 Women’s Health Market Share Forecast by Type 2024, 2029, 2034 (%)
Figure 68 Generic Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 69 Generic Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Branded Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 71 Branded Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Women’s Health Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 73 Women’s Health Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 74 Women’s Health Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 75 North America Women’s Health Market Attractiveness Index
Figure 76 North America Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 77 North America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 78 North America Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 79 North America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 80 North America Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 81 North America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 82 North America Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 83 North America Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 84 North America Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 85 North America Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 86 North America Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 87 U.S. Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Canada Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 89 Europe Women’s Health Market Attractiveness Index
Figure 90 Europe Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 91 Europe Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 92 Europe Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 93 Europe Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 94 Europe Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 95 Europe Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 96 Europe Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 97 Europe Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 98 Europe Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 99 Europe Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 100 Europe Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 101 Germany Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 France Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 UK Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 Italy Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Spain Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 106 Russia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 107 Poland Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 108 Belgium Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Rest of Europe Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Asia Pacific Women’s Health Market Attractiveness Index
Figure 111 Asia Pacific Women’s Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
Figure 112 Asia Pacific Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 113 Asia Pacific Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 114 Asia Pacific Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 115 Asia Pacific Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 116 Asia Pacific Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 117 Asia Pacific Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 118 Asia Pacific Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 119 Asia Pacific Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 120 Asia Pacific Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 121 Asia Pacific Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 122 Japan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 China Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 India Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 Australia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 South Korea Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Singapore Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Taiwan Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Rest of Asia Pacific Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Latin America Women’s Health Market Attractiveness Index
Figure 131 Latin America Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 132 Latin America Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 133 Latin America Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 134 Latin America Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 135 Latin America Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 136 Latin America Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 137 Latin America Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 138 Latin America Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 139 Latin America Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 140 Latin America Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 141 Latin America Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 142 Brazil Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 143 Mexico Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 144 Argentina Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 145 Colombia Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 146 Rest of Latin America Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 147 MEA Women’s Health Market Attractiveness Index
Figure 148 MEA Women’s Health Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 149 MEA Women’s Health Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 150 MEA Women’s Health Market Share Forecast by Country, 2024 & 2034 (%)
Figure 151 MEA Women’s Health Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 152 MEA Women’s Health Market Share Forecast by Application, 2024 & 2034 (%)
Figure 153 MEA Women’s Health Market Forecast by Distribution Channel, 2024-2034 (US$ Billion, AGR %)
Figure 154 MEA Women’s Health Market Share Forecast by Distribution Channel, 2024 & 2034 (%)
Figure 155 MEA Women’s Health Market Forecast by Drugs, 2024-2034 (US$ Billion, AGR %)
Figure 156 MEA Women’s Health Market Share Forecast by Drugs, 2024 & 2034 (%)
Figure 157 MEA Women’s Health Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 158 MEA Women’s Health Market Share Forecast by Type, 2024 & 2034 (%)
Figure 159 GCC Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 160 South Africa Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 161 Rest of MEA Women’s Health Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 162 Women Health Market Company Share, 2022
Figure 163 Abbott Laboratories: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 164 Abbott Laboratories: R&D, 2017-2022 (US$ Million, AGR%)
Figure 165 Bayer AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 166 Bayer AG : R&D, 2017-2022 (US$ Million, AGR%)
Figure 167 Bayer AG: Regional Market Shares, 2022
Figure 168 Cardinal Health: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 169 Cardinal Health: Regional Market Shares, 2023
Figure 170 Cooper Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 171 Cooper Surgical, Inc.: R&D, 2017-2023 (US$ Million, AGR%)
Figure 172 Cooper Surgical, Inc.: Regional Market Shares, 2023
Figure 173 L. Hoffman-La Roche Ltd.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 174 L. Hoffman-La Roche Ltd.: R&D, 2017-2023 (US$ Million, AGR%)
Figure 175 General Electric Healthcare: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 176 General Electric Healthcare: R&D, 2017-2022 (US$ Million, AGR%)
Figure 177 General Electric Healthcare: Regional Market Shares, 2022
Figure 178 Hologic Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 179 Hologic Inc: R&D, 2017-2023 (US$ Million, AGR%)
Figure 180 Hologic Inc: Regional Market Shares, 2022
Figure 181 Koninklijke Philips N.V: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 182 Koninklijke Philips N.V: R&D, 2017-2022 (US$ Million, AGR%)
Figure 183 Prestige Consumer Healthcare Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 184 Siemens AG: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 185 Siemens AG: R&D, 2017-2023 (US$ Million, AGR%)
Figure 186 Siemens AG: Regional Market Shares, 2023
List of Companies Profiled in the Report
Abbott
Bayer AG
Caldera Medical
Cardinal Health
Carestream
Cooper Surgical Inc.
L. Hoffman-La Roche Ltd.
GE Healthcare
Hologic
Koninklijke Philips N.V
MedGyn Products
Medline Industries, Inc.
Prestige Consumer Healthcare, Inc.
Siemens AG
List of Other Companies Mentioned in the Report
2SAN
AbbVie
Aché Laboratórios
Alpha Pharma
Ambio
Amgen's
Bayer
BioSyent
Boehringer Ingelheim
Celmatix
Cipla
Dame
Disproquima
Elda Health
Eli Lilly
Eris Lifesciences
Evenity & nbsp
FemTherapeutics
Fuji Pharma
Future Fertility
GlaxoSmithKline
Henlius
Heranova Lifesciences
Knight Therapeutics
mAbxience
Menarini
Mckinsey
Mithra Biotech
MSD Korea
Myovant Sciences
Nuvo Group
Organon
Perrigo
Pfizer
Plenna
Pro Mujer
Qi Health
Res Pharma
Samsung
Sandoz
Stemline Therapeutics
Solera Health
Talkspace
Teva Pharmaceutical
Unified Women's Healthcare
Weber Shandwick
List of Associations Mentioned in the Report
Australian drug regulatory TGA
CAF, Development Bank of Latin America
Canadian Institutes of Health Research
European Medicines Agency (EMA),
Government of Canada
Gulf Cooperation Council (GCC)
Hard Rock Heals Foundation
Italian Medicines Agency (Aifa)
Medicines and Healthcare Products Regulatory Agency, England
National Health Service (NHS) in the United Kingdom.
Women and Gender Equality Canada
World Bank
The Pricing and Reimbursement Committee (CPR)
The Ministry of Health, Mexico
World Economic Forum (WEF)
U.S. FDA
United Nations Children's Fund (UNICEF)
World Health Organization WHO
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
